H. Yamazaki et al., ACTIVATION OF TRANS-1,2-DIHYDRO-1,2-DIHYDROXY-6-AMINOCHRYSENE TO GENOTOXIC METABOLITES BY RAT AND HUMAN CYTOCHROMES P450, Carcinogenesis, 15(3), 1994, pp. 465-470
In order to address the hypothesis that 6-aminochrysene (6-AC) is conv
erted to genotoxic products by cytochrome P450 enzymes via two activat
ion pathways (N-hydroxylation and epoxidation), the activation of 6-AC
and trans-1,2-dihydro-1,2-dihydroxy-6-aminochrysen (6-AC-diol) to gen
otoxic metabolites was examined in rat and human liver microsomal cyto
chrome P450 enzymes using Salmonella typhimurium TA1535/pSK1002 and TA
1535/pSK1002/pNM12 (NM2009) as tester strains. The latter bacteria, an
O-acetyl-transferase-overexpressing strain, was highly sensitive to m
etabolites derived from activation of 6-AC, but not those from 6-AC-di
ol, using liver microsomes from phenobarbital-treated rats or a recons
tituted monooxygenase system containing P4502B1 or -2B2, thus suggesti
ng the roles of P450 and acetyltransferase systems in the activation p
rocess. 6-AC-diol, on the other hand, was activated very efficiently b
y liver microsomes prepared from beta-naphthoflavone-treated rats or a
reconstituted system containing P4501A1 or -1A2; the activation react
ion is considered to proceed through diolepoxide formation. The contri
bution of rat P4501A enzymes towards activation of 6-AC-diol was confi
rmed by the inhibitory effects on the activation process of alpha-naph
thoflavone, a specific inhibitor of P4501A-related activities, and ant
ibodies raised against purified P4501A1 and -1A2. In humans, P4501A2 w
as found to be the major enzyme involved in the activation of 6-AC-dio
l to genotoxic metabolites while the parent compound 6-AC was activate
d mainly by P4503A4. Experiments using recombinant P450. proteins expr
essed in human lymphoblastoid cell lines showed that human P4501A1 cou
ld also activate 6-AC-diol to reactive metabolites at almost the same
rate measured,vith P4501A2. In addition, P4502B6 was found to efficien
tly catalyze the activation of 6-AC to genotoxic metabolites, and P450
3A4 was active in the activation of 6-AC-diol as well as 6-AC. Additio
n of purified rat epoxide hydrolase to the incubation mixture containi
ng purified rat P4501A1 or microsomes expressing human P4501A1 caused
inhibition of activation of 6-AC-diol. These results suggest the exist
ence of different enzymatic activation pathways for 6-AC and 6-AC-diol
. The former carcinogen may be N-hydroxylated principally by P4502B en
zymes in rats and P4503A4 and -2B6 in humans and activation to its ult
imate metabolites may proceed through esterification of the N-hydroxy
metabolites by an N-acetyltransferase. The 6-AC-diol is metabolized to
its ultimate diolepoxide product by P4501A enzymes in rat and human l
iver microsomes. P4503A4 (humans) and P4503A2 (rats) may also contribu
te to some extent in the activation of Q-AC-diol, albeit at lower rate
s than those of P4501A enzymes.